Plasmodium falciparum 19-Kilodalton Merozoite Surface Protein 1 (MSP1)-Specific Antibodies That Interfere with Parasite Growth In Vitro Can Inhibit MSP1 Processing, Merozoite Invasion, and Intracellular Parasite Development

Merozoite surface protein 1 (MSP1) is a target for malaria vaccine development. Antibodies to the 19-kDa carboxy-terminal region referred to as MSP119 inhibit erythrocyte invasion and parasite growth, with some MSP1-specific antibodies shown to inhibit the proteolytic processing of MSP1 that occurs at invasion. We investigated a series of antibodies purified from rabbits immunized with MSP119 and AMA1 recombinant proteins for their ability to inhibit parasite growth, initially looking at MSP1 processing. Although significant inhibition of processing was mediated by several of the antibody samples, there was no clear relationship with overall growth inhibition by the same antibodies. However, no antibody samples inhibited processing but not invasion, suggesting that inhibition of MSP1 processing contributes to but is not the only mechanism of antibody-mediated inhibition of invasion and growth. Examining other mechanisms by which MSP1-specific antibodies inhibit parasite growth, we show that MSP119-specific antibodies are taken up into invaded erythrocytes, where they persist for significant periods and result in delayed intracellular parasite development. This delay may result from antibody interference with coalescence of MSP119-containing vesicles with the food vacuole. Antibodies raised against a modified recombinant MSP119 sequence were more efficient at delaying intracellular growth than those to the wild-type protein. We propose that antibodies specific for MSP119 can mediate inhibition of parasite growth by at least three mechanisms: inhibition of MSP1 processing, direct inhibition of invasion, and inhibition of parasite development following invasion. The balance between mechanisms may be modulated by modifying the immunogen used to induce the antibodies.

[1]  H. Bujard,et al.  Regulated maturation of malaria merozoite surface protein-1 is essential for parasite growth , 2010, Molecular microbiology.

[2]  H. Bujard,et al.  Antibodies against multiple merozoite surface antigens of the human malaria parasite Plasmodium falciparum inhibit parasite maturation and red blood cell invasion , 2010, Malaria Journal.

[3]  C. G. Black,et al.  Growth-Inhibitory Antibodies Are Not Necessary for Protective Immunity to Malaria Infection , 2009, Infection and Immunity.

[4]  S. Howell,et al.  Inhibition of Erythrocyte Invasion and Plasmodium falciparum Merozoite Surface Protein 1 Processing by Human Immunoglobulin G1 (IgG1) and IgG3 Antibodies , 2009, Infection and Immunity.

[5]  A. Holder.  Malaria Vaccines: Where Next? , 2009, PLoS pathogens.

[6]  E. Bergmann-Leitner,et al.  MSP-1p42-specific antibodies affect growth and development of intra-erythrocytic parasites of Plasmodium falciparum , 2009, Malaria Journal.

[7]  A. Holder.  The carboxy-terminus of merozoite surface protein 1: structure, specific antibodies and immunity to malaria , 2009, Parasitology.

[8]  A. Dicko,et al.  A randomized controlled phase 2 trial of the blood stage AMA1-C1/Alhydrogel malaria vaccine in children in Mali. , 2009, Vaccine.

[9]  S. Thiberge,et al.  Clonal conditional mutagenesis in malaria parasites. , 2009, Cell host & microbe.

[10]  V. A. Stewart,et al.  Blood Stage Malaria Vaccine Eliciting High Antigen-Specific Antibody Concentrations Confers No Protection to Young Children in Western Kenya , 2009, PloS one.

[11]  M. Kieny,et al.  Comparison of immunogenicity of five MSP1-based malaria vaccine candidate antigens in rabbits. , 2009, Vaccine.

[12]  M. Grainger,et al.  Formation of the Food Vacuole in Plasmodium falciparum: A Potential Role for the 19 kDa Fragment of Merozoite Surface Protein 1 (MSP119) , 2008, PloS one.

[13]  A. Thomas,et al.  Comparative Testing of Six Antigen-Based Malaria Vaccine Candidates Directed Toward Merozoite-Stage Plasmodium falciparum , 2008, Clinical and Vaccine Immunology.

[14]  P. Gilson,et al.  MSP119 miniproteins can serve as targets for invasion inhibitory antibodies in Plasmodium falciparum provided they contain the correct domains for cell surface trafficking , 2008, Molecular microbiology.

[15]  A. Thomas,et al.  Malaria Vaccine-Related Benefits of a Single Protein Comprising Plasmodium falciparum Apical Membrane Antigen 1 Domains I and II Fused to a Modified Form of the 19-Kilodalton C-Terminal Fragment of Merozoite Surface Protein 1 , 2007, Infection and Immunity.

[16]  A. Holder,et al.  The Importance of Human FcγRI in Mediating Protection to Malaria , 2007, PLoS pathogens.

[17]  A. Thomas,et al.  Fine Mapping of an Epitope Recognized by an Invasion-inhibitory Monoclonal Antibody on the Malaria Vaccine Candidate Apical Membrane Antigen 1* , 2007, Journal of Biological Chemistry.

[18]  E. Bergmann-Leitner,et al.  Critical evaluation of different methods for measuring the functional activity of antibodies against malaria blood stage antigens. , 2006, The American journal of tropical medicine and hygiene.

[19]  C. Withers-Martinez,et al.  Molecular Identification of a Malaria Merozoite Surface Sheddase , 2005, PLoS pathogens.

[20]  A. Thomas,et al.  Mode of Action of Invasion-Inhibitory Antibodies Directed against Apical Membrane Antigen 1 of Plasmodium falciparum , 2005, Infection and Immunity.

[21]  M. Grainger,et al.  Precise epitope mapping of malaria parasite inhibitory antibodies by TROSY NMR cross-saturation. , 2005, Biochemistry.

[22]  A. Holder,et al.  The Fine Specificity, but Not the Invasion Inhibitory Activity, of 19-Kilodalton Merozoite Surface Protein 1-Specific Antibodies Is Associated with Resistance to Malarial Parasitemia in a Cross-Sectional Survey in The Gambia , 2004, Infection and Immunity.

[23]  A. Holder,et al.  Fine Specificity of Serum Antibodies to Plasmodium falciparum Merozoite Surface Protein, PfMSP-119, Predicts Protection from Malaria Infection and High-Density Parasitemia , 2004, Infection and Immunity.

[24]  J. K. Moch,et al.  Invasion-inhibitory antibodies inhibit proteolytic processing of apical membrane antigen 1 of Plasmodium falciparum merozoites , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[25]  S. Howell,et al.  A Single Malaria Merozoite Serine Protease Mediates Shedding of Multiple Surface Proteins by Juxtamembrane Cleavage* , 2003, Journal of Biological Chemistry.

[26]  F. Nato,et al.  Crystal structure of a Fab complex formed with PfMSP1-19, the C-terminal fragment of merozoite surface protein 1 from Plasmodium falciparum: a malaria vaccine candidate. , 2003, Journal of molecular biology.

[27]  A. Holder,et al.  Inhibitory and blocking monoclonal antibody epitopes on merozoite surface protein 1 of the malaria parasite Plasmodium falciparum. , 2001, Journal of molecular biology.

[28]  W. Taylor,et al.  The merozoite surface protein 6 gene codes for a 36 kDa protein associated with the Plasmodium falciparum merozoite surface protein-1 complex. , 2001, Molecular and biochemical parasitology.

[29]  A. Holder,et al.  Merozoite surface protein 1, immune evasion, and vaccines against asexual blood stage malaria. , 1999, Parassitologia.

[30]  A. Holder,et al.  Solution structure of an EGF module pair from the Plasmodium falciparum merozoite surface protein 1. , 1999, Journal of molecular biology.

[31]  A. Holder,et al.  Antibodies that Inhibit Malaria Merozoite Surface Protein–1 Processing and Erythrocyte Invasion Are Blocked by Naturally Acquired Human Antibodies , 1997, The Journal of experimental medicine.

[32]  A. Holder,et al.  Antibodies inhibit the protease-mediated processing of a malaria merozoite surface protein , 1994, The Journal of experimental medicine.

[33]  A. Holder,et al.  Secondary processing of the Plasmodium falciparum merozoite surface protein-1 (MSP1) by a calcium-dependent membrane-bound serine protease: shedding of MSP133 as a noncovalently associated complex with other fragments of the MSP1. , 1992, Molecular and biochemical parasitology.

[34]  H. Whittle,et al.  Processing of the Plasmodium falciparum major merozoite surface protein-1: identification of a 33-kilodalton secondary processing product which is shed prior to erythrocyte invasion. , 1991, Molecular and biochemical parasitology.

[35]  A. Holder,et al.  A single fragment of a malaria merozoite surface protein remains on the parasite during red cell invasion and is the target of invasion- inhibiting antibodies , 1990, The Journal of experimental medicine.

[36]  M. Perkins,et al.  Sialic acid-dependent binding of Plasmodium falciparum merozoite surface antigen, Pf200, to human erythrocytes. , 1988, Journal of immunology.

[37]  J. McBride,et al.  Fragments of the polymorphic Mr 185,000 glycoprotein from the surface of isolated Plasmodium falciparum merozoites form an antigenic complex. , 1987, Molecular and biochemical parasitology.

[38]  C. Dolea,et al.  World Health Organization , 1949, International Organization.

[39]  M. Grainger,et al.  Extensive proteolytic processing of the malaria parasite merozoite surface protein 7 during biosynthesis and parasite release from erythrocytes. , 2007, Molecular and biochemical parasitology.

[40]  P. Gerold,et al.  Structural analysis of the glycosyl-phosphatidylinositol membrane anchor of the merozoite surface proteins-1 and -2 of Plasmodium falciparum. , 1996, Molecular and biochemical parasitology.

[41]  M. Blackman,et al.  Purification of Plasmodium falciparum merozoites for analysis of the processing of merozoite surface protein-1. , 1994, Methods in cell biology.